Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.06% |
| 2 | Technology | 13.71% |
| 3 | Financials | 10.21% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Lam Research
LRCX
$408B
| $37.5M | 0.04% |
2,037,560
-4,767,000
| -70% | -$93.7M |
|
577
Cemex
CX
$16.2B
| $37.4M | 0.04% |
4,981,493
-3,761,600
| -43% | -$29.7M |
|
578
W.R. Berkley
WRB
$25.9B
| $37.3M | 0.04% |
1,755,675
+637,537
| +57% | +$13M |
|
579
Exponent
EXPO
$3.22B
| $37.2M | 0.04% |
1,047,200
+80,336
| +8% | +$2.95M |
|
580
Wynn Resorts
WYNN
$10.6B
| $37.2M | 0.04% |
220,600
-56,700
| -20% | -$8.74M |
|
581
Copart
CPRT
$26.8B
| $37.2M | 0.04% |
3,442,000
+3,065,600
| +814% | +$29.8M |
|
582
Rush Enterprises Class A
RUSHA
$9.41B
| $37.1M | 0.04% |
1,644,926
+462,150
| +39% | +$10M |
|
583
United Microelectronic
UMC
$48.4B
| $37.1M | 0.04% |
15,525,289
+1,513,000
| +11% | +$3.86M |
|
|
PRA
584
DELISTED
ProAssurance
PRA
| $36.9M | 0.04% |
645,500
+33,111
| +5% | +$1.93M |
|
585
AES
AES
$10.5B
| $36.8M | 0.04% |
3,394,400
-461,300
| -12% | -$4.99M |
|
586
Mercury Insurance
MCY
$5.84B
| $36.8M | 0.04% |
687,831
+301,131
| +78% | +$16.6M |
|
587
Raymond James Financial
RJF
$34.9B
| $36.7M | 0.04% |
+616,505
| New | +$35.5M |
|
|
DNKN
588
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $36.7M | 0.04% |
568,700
-125,900
| -18% | -$7.34M |
|
589
CAE Inc. Common Shares
CAE
$8.9B
| $36.6M | 0.04% |
1,974,100
+3,800
| +0.2% | +$67.2K |
|
|
TPH
590
DELISTED
Tri Pointe Homes
TPH
| $36.6M | 0.04% |
+2,041,936
| New | +$34.4M |
|
|
KYO
591
DELISTED
Kyocera Adr
KYO
| $36.5M | 0.04% |
557,564
+2,564
| +0.5% | +$173K |
|
592
Newmont
NEM
$124B
| $36.4M | 0.04% |
971,100
-947,700
| -49% | -$34.9M |
|
593
Oneok
OKE
$58.3B
| $36.2M | 0.04% |
+677,814
| New | +$36.2M |
|
594
Armstrong World Industries
AWI
$7.75B
| $36.2M | 0.04% |
598,200
+308,900
| +107% | +$17M |
|
595
West Pharmaceutical
WST
$24.8B
| $36.2M | 0.04% |
366,500
-54,000
| -13% | -$5.29M |
|
596
Carlyle Group
CG
$17.2B
| $36.1M | 0.04% |
1,576,775
+402,475
| +34% | +$8.99M |
|
597
Pfizer
PFE
$150B
| $36.1M | 0.04% |
1,050,460
-4,861,153
| -82% | -$166M |
|
|
CDK
598
DELISTED
CDK Global, Inc.
CDK
| $36.1M | 0.04% |
506,200
-681,100
| -57% | -$45.7M |
|
599
Valero Energy
VLO
$95.1B
| $35.9M | 0.04% |
390,988
-372,800
| -49% | -$30.8M |
|
600
American Financial Group
AFG
$12B
| $35.8M | 0.04% |
329,900
+114,900
| +53% | +$12.1M |
|
Similar funds
Jim Simons's Q4 2017 Portfolio in Review
As of Q4 2017, Jim Simons held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Jim Simons's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Jim Simons added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Jim Simons's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Jim Simons fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Jim Simons's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Jim Simons opened 521 new positions and closed 386 in Q4 2017.
- Jim Simons's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.